Logotype for Bio-Rad Laboratories Inc

Bio-Rad Laboratories (BIO) investor relations material

Bio-Rad Laboratories Wells Fargo 20th Annual Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Bio-Rad Laboratories Inc
Wells Fargo 20th Annual Healthcare Conference 2025 summary4 Sep, 2025

Financial and operational highlights

  • Q2 saw strong revenue, driven by process chromatography and consumables, with operating margin improvement due to tariff stabilization and tight expense management.

  • Free cash flow was robust, and the Stillia acquisition was completed, with positive customer feedback and pipeline growth.

  • The company raised its full-year guide for process chromatography, expecting low double-digit growth, and sees improved visibility and stability in this segment.

  • Diagnostics ex-China grew 3.7% in Q2, with Quality Systems as a key contributor; China remains a headwind due to reimbursement changes.

  • Tariff headwinds have been largely mitigated, with only a 30–40 basis point impact expected for the rest of the year.

Market and segment trends

  • Biopharma instrument demand remains soft, especially among smaller players, while consumables show steady activity; large pharma has stabilized.

  • Academic and government (A&G) markets in the US are stable but cautious, awaiting NIH budget clarity; Europe faces pressure from budget shifts, and China remains challenged.

  • ddPCR portfolio expansion, including the launch of Continuum, is expected to drive mid single-digit growth in the near term, with long-term goals of high single-digit to double-digit growth.

  • Adoption of digital PCR in diagnostics is in early stages, with growth opportunities in oncology and rare event detection.

  • The Stillia acquisition is expected to reach accretion within 18–24 months, with ongoing updates based on market uptake.

Strategic initiatives and outlook

  • Supply chain improvements, including lean manufacturing and logistics consolidation, have increased productivity and capacity, especially in Singapore.

  • Working capital efficiency is a focus, with initiatives to improve inventory turns and procurement leverage, aiming for better free cash flow.

  • Q4 revenue ramp is expected, driven by Quality Systems lot releases and ddPCR portfolio sales; 4–5% organic growth is anticipated for Q4, but 2026 guidance remains cautious.

  • Margin expansion requires at least 3% top-line growth, with SG&A leverage targeted through productivity and expense management.

  • Capital allocation priorities include reinvestment in the business, strategic acquisitions, and opportunistic share repurchases.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Bio-Rad Laboratories earnings date

Logotype for Bio-Rad Laboratories Inc
Q3 202529 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Bio-Rad Laboratories earnings date

Logotype for Bio-Rad Laboratories Inc
Q3 202529 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Bio-Rad Laboratories Inc develops, manufactures, and markets products for the life science research and clinical diagnostics markets. The company provides instruments, reagents, software, and services used in scientific discovery, biotechnology research, and medical diagnostics. Its products support laboratories, universities, hospitals, and research institutions worldwide. The company is headquartered in Hercules, California, and its shares are listed on the NYSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage